Whitehawk Therapeutics, Inc.·4

Jun 15, 5:27 PM ET

Zhao Baiteng 4

4 · Whitehawk Therapeutics, Inc. · Filed Jun 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Whitehawk (WHWK) Director Zhao Baiteng Receives Award of 38,040 Shares

What Happened

  • Director Zhao Baiteng received a grant/award covering 38,040 shares on June 12, 2026. The Form 4 lists the acquisition price as $0.00 and classifies the transaction as a derivative award (option-related). The filing was submitted on June 15, 2026.

Key Details

  • Transaction date: 2026-06-12; Form 4 filed: 2026-06-15 (timely within reporting window).
  • Reported amount: 38,040 shares; reported price: $0.00 (derivative award).
  • Vesting/conditions (footnote): Award is subject to continued service; 100% of the shares subject to the option vest on the earlier of (i) the one-year anniversary of the grant (June 12, 2027) or (ii) the day before the next annual meeting of stockholders. Grant is under the issuer’s 2021 Equity Incentive Plan.
  • Shares owned after the transaction are not provided in the excerpt of the filing.
  • No 10b5-1 plan, tax-withholding, cashless exercise, or sale was indicated in this filing.

Context

  • This is a grant of option/derivative awards, not an open-market purchase or sale. Such awards are compensation-related and subject to vesting; they do not by themselves indicate buying or selling intent by the insider.
  • For retail investors, award grants are routine executive/director compensation events. Purchases (outright buys) are often considered the stronger signal of personal conviction, while grants mainly reflect company compensation policies.

Insider Transaction Report

Form 4
Period: 2026-06-12
Zhao Baiteng
Director
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-06-12+38,04038,040 total
    Exercise: $4.16Exp: 2036-06-12Common Stock (38,040 underlying)
Footnotes (1)
  • [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2026.
Signature
/s/ Stephen Rodin, as Attorney-in-Fact|2026-06-15

Documents

1 file
  • 4
    form4-06152026_090634.xmlPrimary